Inipharm

Private

Bellevue, WashingtonHealthcare & Life Scienceshttps://inipharm.com/

Last Round

Series A

Nov 11, 2020

Total Funding Raised

$35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Inipharm is a biopharmaceutical company specializing in the discovery and development of small-molecule therapies for severe liver diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

metabolic dysfunction-associated steatohepatitisMASHHSD17B13 inhibitorsmall molecule therapeuticsliver diseaseliver fibrosisclinical-stage biopharmadrug discoveryhepatologyliver homeostasisfatty liver diseasebiotech startupclinical trialpharmacokinetic dataNASH drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inipharm Comps

Public and private peers based on sector, stage, and business model.

Inipharm comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Inipharm Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Nov 11, 2020

View all Funding Rounds

Inipharm Investors

Notable investors and investment history

Inipharm investors
Investor	Rounds
Frazier Healthcare Partners	Series A
Wu Capital	Series A
5AM Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 19, 2026
Monthly visitors grew 37% MoM.

View all signals

Inipharm Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Inipharm Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inipharm's valuation, stock price, and market status.

Firmographic Details

HeadquartersBellevue, Washington

Employee Range7

Year Founded2018

Last FundingNov 11, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.